Viking Therapeutics (VKTX) Misses Q2 EPS by 13c
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.58), $0.13 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.